Filter
5591
Filtered Results: 5591
Text search:
clinical
studies
Featured
Recommendations
515
New Publications
1212
Language
Document type
No document type
3080
Studies & Reports
1021
Guidelines
769
Manuals
286
Strategic & Response Plan
137
Fact sheets
129
Training Material
105
Situation Updates
26
Resource Platforms
19
Infographics
8
Brochures
6
Online Courses
2
Videos
2
App
1
Countries / Regions
India
287
Global
209
Kenya
141
South Africa
139
Western and Central Europe
114
Ethiopia
107
Uganda
98
Sierra Leone
92
Tanzania
89
Africa
82
Latin America and the Carribbean
81
Zambia
81
Nepal
79
Nigeria
79
Liberia
78
Rwanda
72
Ghana
70
Malawi
61
Bangladesh
61
Ukraine
47
Myanmar / Burma
43
Philippines
40
Eastern Europe
40
Brazil
40
Germany
38
Russia
37
Namibia
37
Zimbabwe
35
Asia
31
Indonesia
31
South–East Asia Region
30
Syria
29
Mozambique
28
Cambodia
28
Lesotho
27
East and Southern Africa
27
Congo, Democratic Republic of
26
West and Central Africa
25
Guinea
22
Colombia
21
Botswana
20
Senegal
19
Burkina Faso
17
South Sudan
17
USA
16
Venezuela
16
Cameroon
15
Haiti
15
Middle East and North Africa
15
Eastern Europe and Central Asia
15
Eswatini/ Swaziland
15
Tajikistan
14
Pakistan
12
Peru
11
Benin
10
China
10
Albania
10
Afghanistan
10
Thailand
9
Chile
9
Sudan
9
Georgia
9
North America
8
Vietnam
8
Ecuador
8
North Macedonia
7
Armenia
7
Western Pacific Region
7
Southern Africa
7
Argentina
7
Sri Lanka
7
Angola
7
Laos
6
Lebanon
6
Yemen
6
Somalia
6
Madagascar
6
Jordan
5
United Kingdom
5
Moldova
5
Mali
5
Turkey
4
Iran
4
Kyrgyzstan
4
Paraguay
4
Central African Republic
4
Iraq
4
Kazakhstan
3
Canada
3
Japan
3
Spain
3
Côte d’Ivoire / Ivory Coast
3
Bolivia
3
Chad
3
Bhutan
3
Timor Leste/ East Timor
2
Mexico
2
Serbia
2
Gambia
2
Estonia
2
Uzbekistan
2
Burundi
2
Guinea-Bissau
2
Saudi Arabia
2
Gabon
2
Jamaica
2
Belgium
2
Belarus
2
Papua New Guinea
2
Egypt
2
Libya
2
North Korea
1
Switzerland
1
El Salvador
1
Singapore
1
Malaysia
1
Morocco
1
Qatar
1
Bulgaria
1
Italy
1
Lithuania
1
Ireland
1
Uruguay
1
Turkmenistan
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Portugal
1
Israel
1
Latvia
1
Greece
1
Palestine
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1891
Clinical Guidelines
537
Public Health
310
Women & Child Health
282
Key Resources
176
Capacity Building
126
Pharmacy & Technologies
70
Toolboxes
Mental Health
641
HIV
513
COVID-19
476
TB
400
NTDs
238
AMR
207
Caregiver
194
Rapid Response
160
NCDs
150
Disability
135
Ebola & Marburg
119
Planetary Health
111
Pharmacy
104
Conflict
67
Global Health Education
66
Malaria
61
Refugee
59
Zika
47
Health Financing Toolbox
32
Social Ethics
27
Cholera
23
Polio
20
Natural Hazards
18
Specific Hazards
16
May 9, 2022.Since the onset of the COVID-19 pandemic, a large number of clinical trials have been planned and developed to assess the effectiveness and safety of various interventions that could prevent hospitalizations and progression to severe disease in people infected with SARS-CoV-2. Currently,...
The effect of music intervention on mild and moderate Intellectually
disabled children was studied in non-randomized pre-test post-test control
group design at an Indian state (Jammu) J&K
This chapter discusses the antibacterial treatment of leprosy infections. Antibiotic treatment is
a key component of leprosy treatment, as it is vital to prevent the progression of the infection.
Treatment with rifampin and other antibiotics is highly effective and cures 98% of patients with
the ...
Noncommunicable diseases (NCDs) such as cancer, cardiovascular diseases, diabetes and chronic respiratory diseases and their risk factors are an increasing public health and development challenge in Kyrgyzstan. This report provides evidence through three analyses that NCDs reduce economic outp...
The toolkit aims to provide researchers with guidance for improving the quality of studies that use administrative data to better ascertain child maltreatment incidence, response and service delivery. However, these are complex studies to conduct, and the toolkit is not meant to be comprehensive. Re...
WHO recommends artemisinin-based combination therapies for treating uncomplicated malaria, alongside studies to monitor treatment effectiveness. Given the threat of antimalarial resistance, including partial resistance in several African countries, molecular tools are vital for tracking resistance. ...
This article is part four in a series of explainers on vaccine development and distribution.
Part one focused on how vaccines work to protect our bodies from disease-carrying germs.
Part two focused on the ingredients in a vaccine and the three clinical trial phases.
Part three focused on the ste...
Antimalarial drug resistance has emerged as a threat to global malaria control efforts, particularly in the Greater Mekong subregion. Drawing on data collected through more than 1000 therapeutic efficacy studies as well as molecular marker studies of Plasmodium falciparum drug resistance, the Report...
Cystic echinococcosis (CE) is a well-known neglected parasitic disease. However, evidence supporting the four current treatment modalities is inadequate, and treatment options remain controversial. The aim of this work is to analyse the available data to answer clinical questions regarding medical t...
Atherosclerotic lower-extremity peripheral artery disease (PAD) is increasingly recognized as an important cause of cardiovascular morbidity and mortality that affects more than 230 million people worldwide. Traditional cardiovascular risk factors, including advanced age, smoking, and diabetes, are ...
This version of Field Trials of Health Interventions includes seven new chapters on conducting systematic literature reviews, trial
governance, preliminary studies and pilot testing, budgeting and accounting, intervention costing and economic analysis, and Phase IV studies. Before new interventions...
This document is part three in a series of explainers on vaccine development and distribution. Part one focused on how vaccines work to protect our bodies from disease-carrying germs. Part two focused on the ingredients in a vaccine and the three clinical trial phases.
This document outlines the...
Manufacturers:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
Efficacy shown in clinical trials in participants who received the full series of vaccine (2 doses) ir...
This document focuses on making recommendations for the diagnosis and treatment of Chagas disease, an infection caused by Trypanosoma cruzi, the protozoan agent of a systemic parasitic disease. Methodology: These clinical practice guidelines were prepared following the WHO handbook for guideline dev...
Chapter 2 in "Latest Findings in Intellectual and Developmental Disabilities Research" Edited by Üner Tan, ISBN 978-953-307-865-6, 404 pages, Publisher: InTech, Chapters published February 15, 2012 under CC BY 3.0 license | Intellectual and Developmental Disabilities presents reports on a wide rang...
The recommendations in this guideline are intended to inform development of national and subnational health policies, clinical protocols and programmatic guides. The target audience includes national and subnational public health policy-makers, implementers and managers of maternal, newborn and chil...
Laboratory biosafety manual
recommended
4th edition
The WHO Laboratory Biosafety Manual (LBM) has been in broad use at all levels of clinical and public health laboratories, and other biomedical sectors globally, serving as a de facto global standard that presents best practices and sets trends in biosafety.
LBM encouraged countries t...
Medicina 2019, 55, 553; doi:10.3390/medicina55090553
Results: Twenty-one studies were analyzed, most of them demonstrating an association between the existence of burnout and the worsening of patient safety. High levels of burnout is more common among physicians and nurses, and it is associated wit...
This Rapid Advice Guideline updates the Interim Guidance on the “Assessment of infants with microcephaly in the context of Zika virus” published in February 2016 (WHO/ZIKV/MOC/16.3). The recommendations provides guidance on the screening, clinical assessment, neuroimaging, laboratory investigati...
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported ...
